Sun.Sep 15, 2024

article thumbnail

FOMC Preview: Fed to Cut Rates

Calculated Risk

Most analysts expect the FOMC will cut the federal funds rate at the meeting this week by 25bp lowering the target range to 5 to 5-1/4 percent. It is possible the FOMC will cut by 50bp. Currently market participants are split evenly between a 25bp and a 50bp cut this week. Market participants are also pricing in a total of 75bp in cuts by the November meeting, and between 100bp to 125bp in cuts by December.

Banking 312
article thumbnail

Top clicks this week on Abnormal Returns

Abnormal Returns

Also on the site Elder financial fraud is only going up. Maybe AI can help. (abnormalreturns.com) Noted personal finance writer Jonathan Clements is dying. He still has plenty left to teach us. (abnormalreturns.com) Top clicks this week How the new AirPod Pros 2 could upend the hearing aid industry. (cnbc.com) Sometimes things really are different this time.

Portfolio 298
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sunday Night Futures

Calculated Risk

Weekend: • Schedule for Week of September 15, 2024 • FOMC Preview: Fed to Cut Rates Monday: • 8:30 AM ET: The New York Fed Empire State manufacturing survey for September. The consensus is for a reading of -4.0, up from -4.7. From CNBC: Pre-Market Data and Bloomberg futures S&P 500 are up 5 and DOW futures are up 69 (fair value). Oil prices were up over the last week with WTI futures at $68.65 per barrel and Brent at $71.61 per barrel.

article thumbnail

Sunday links: market mood swings

Abnormal Returns

Markets Mortgage rates are back to early 2023 levels. (axios.com) Nvidia ($NVDA) dominates the list of the biggest single-day market cap moves. (visualcapitalist.com) Strategy Are money market fund assets a bond substitute or stock substitute? (awealthofcommonsense.com) Why great companies don't always make for great stocks. (humbledollar.com) ETFs What's left to be ETF'd?

Marketing 275
article thumbnail

Are Robots Replacing You? Keeping Humans in the Loop in Automated Environments

Speaker: Erroll Amacker

As businesses increasingly adopt automation, finance leaders must navigate the delicate balance between technology and human expertise. This webinar explores the critical role of human oversight in accounts payable (AP) automation and how a people-centric approach can drive better financial performance. Join us for an insightful discussion on how integrating human expertise into automated workflows enhances decision-making, reduces fraud risks, strengthens vendor relationships, and accelerates R

article thumbnail

10 Money Revelations in my 40s

A Wealth of Common Sense

I wrote a post almost 10 years ago about money revelations in my 30s. Here’s an updated version now that I’m approaching my mid-40s (dammit Father Time): 1. Lifestyle creep isn’t always bad. Yes, you need to live below your means, delay gratification and avoid overspending. But I am not a fan of living like a pauper when you’re younger just so you can have more money when you’re older.

124
124
article thumbnail

6 items for your not-to-do list

Million Dollar Round Table (MDRT)

By Matt Pais, MDRT Content Specialist You may regularly make a to-do list, but how often do you make a not-to-do list? Try these tactics as an unconventional means of pushing yourself toward exceeding expectations, from past MDRT member Denny Kern Heath, of Kingston, Jamaica.

More Trending

article thumbnail

10 Sunday Reads

The Big Picture

My Sunday morning look at incompetency, corruption and policy failures: • Neither Elon Musk Nor Anybody Else Will Ever Colonize Mars : Mars does not have a magnetosphere. Any discussion of humans ever settling the red planet can stop right there, but of course it never does. Do you have a low-cost plan for, uh, creating a gigantic active dynamo at Mars’s dead core?

article thumbnail

Best Cancer Pharma stock in India 2024 to keep an eye on!

Trade Brains

India is emerging as a major player in the pharmaceutical industry, particularly in the development of cancer drugs. The rising number of cancer cases, both domestic and international, creates immense opportunities for pharmaceutical companies specializing in oncology treatments. As demand for affordable and effective cancer therapies increases, Indian companies are leading in innovation and production.